Results 151 to 160 of about 362,575 (339)
Monoclonal gammopathies in Alzheimer disease [PDF]
, 1994 Tuula Pirttilä +2 more
openalex +1 more source
The N‐glycan profile in cortex and hippocampus is altered in Alzheimer disease [PDF]
, 2020 Stefan Gaunitz +2 more
openalex +1 more source
Advanced Healthcare Materials, EarlyView.Ionizable lipid nanoparticles target multiple pathological pathways in neurodegeneration. The designed self‐assembled materials undergo a pH‐triggered structural transformation from a cubosome/hexosome coexistence to a hexosome phase, enhancing intracellular delivery of a multi‐target phytochemical formulation. The antioxidant‐loaded pH‐responsive LNPs
Thelma Akanchise +4 more
wiley +1 more source
Kelvin Probe Force Microscopy in Bionanotechnology: Current Advances and Future Perspectives
Advanced Materials, EarlyView.Kelvin probe force microscopy (KPFM) enables the nanoscale mapping of electrostatic surface potentials. While widely applied in materials science, its use in biological systems remains emerging. This review presents recent advances in KPFM applied to biological samples and provides a critical perspective on current limitations and future directions for
Ehsan Rahimi +4 more
wiley +1 more source
P4‐296: DIFFERENTIAL NEUROCOGNITIVE NETWORK PERTURBATION IN TYPICAL AND ATYPICAL ALZHEIMER DISEASE [PDF]
, 2018 Adam Martersteck +5 more
openalex +1 more source
Label‐Free SERS Fingerprinting of Neuroprotein Conformational Dynamics in Human Saliva
Advanced Materials, EarlyView.Galvanic molecular entrapment (GME) is a label‐free method for detecting and quantifying neuroprotein conformational states. This technique enables direct surface binding and in situ hotspot generation around molecules, effectively overcoming challenges related to target localization and mismatched hotspot geometries.
Muhammad Shalahuddin Al Ja'farawy +10 more
wiley +1 more source
Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer\u27s disease [PDF]
, 2018 Aschenbrenner, Andrew J +11 more
core +2 more sources
Non‐Invasive Brain Targeted Delivery of Cannabidiol for Alleviating Neuroinflammatory Disease
Advanced Materials, EarlyView.The glucose‐functionalized nanoparticles (GNPs) are developed for the brain‐targeted delivery of cannabidiol (CBD). GNPs bypass the blood‐brain barrier (BBB) via glucose transporter‐1 (GLUT‐1) and release CBD in response to reactive oxygen species (ROS).
Yibin Wang +7 more
wiley +1 more source